Scott A. Holmes
2017 - Keryx Biopharmaceuticals
In 2017, Scott A. Holmes earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at Keryx Biopharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,690 |
|---|---|
| Option Awards | $386,042 |
| Salary | $373,969 |
| Stock Awards | $269,588 |
| Other | $3,824 |
| Total | $1,176,113 |
Holmes received $386K in option awards, accounting for 33% of the total pay in 2017.
Holmes also received $142.7K in non-equity incentive plan, $374K in salary, $269.6K in stock awards and $3.8K in other compensation.
Rankings
In 2017, Scott A. Holmes' compensation ranked 8,205th out of 14,666 executives tracked by ExecPay. In other words, Holmes earned more than 44.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,205 out of 14,666 | 44th |
Division Manufacturing | 3,098 out of 5,772 | 46th |
Major group Chemicals And Allied Products | 1,021 out of 2,075 | 51st |
Industry group Drugs | 803 out of 1,731 | 54th |
Industry Pharmaceutical Preparations | 630 out of 1,333 | 53rd |
Source: SEC filing on May 31, 2018.
Holmes' colleagues
We found four more compensation records of executives who worked with Scott A. Holmes at Keryx Biopharmaceuticals in 2017.